With RAP, ResAppDx is an unique technology with currently no competitor. The OSA diagnosis is also unique, there is one competitor that has gotten regulatory approval mid last year but it only works on iPhone smartphone and certain AHI range unlike RAP's which works on both and all AHI ranges, RMD announced only mid last year they where partnering with Google to develop a mobile diagnosis tool.....and there lies the problem with AHZ (which made it worst by commercialising the medical product themself without using other partners and their connection in this field).
I wish I had fallen in love with CSL.....
Musings of a ‘mug’ RI playing the Stockmarket., page-2
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.88 |
Change
0.130(0.69%) |
Mkt cap ! $361.3M | |||
| Open | High | Low | Value | Volume |
| $18.75 | $18.88 | $18.74 | $52.56K | 2.798K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 54 | $18.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.87 | 517 | 2 |
View Market Depth
| Last trade - 10.55am 18/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$18.89 |
Change
0.130 ( 0.85 %) |
||||
| Open | High | Low | Volume | ||
| $18.88 | $18.89 | $18.87 | 155 | ||
| Last updated 10.56am 18/06/2024 ? | |||||
| AVR (ASX) Chart |
